TherapeuticsMD (TXMD) FCF Margin Growth (3y) (2014 - 2026)
TherapeuticsMD (TXMD) FCF Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 253.00 |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -1,444.00 |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -990.00 |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -2,377.00 |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -1,484.00 |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 4,765.00 |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 1,067.00 |
| 10 | TherapeuticsMD | 280,418.39 | -8.14 Mn | - | 222,654.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 222,654.00 |
| Dec 31, 2025 | 900.00 |
| Sep 30, 2025 | -487,710.00 |
| Jun 30, 2025 | 598,830.00 |
| Mar 31, 2025 | 275,542.00 |
| Dec 31, 2024 | -25,445.00 |
| Sep 30, 2024 | 13,719.00 |
| Jun 30, 2024 | 73,647.00 |
| Mar 31, 2024 | 12,035.00 |
| Dec 31, 2023 | -141,512.00 |
| Sep 30, 2023 | -983,710.00 |
| Jun 30, 2023 | -14,274.00 |
| Mar 31, 2023 | -177,674.00 |
| Dec 31, 2022 | 35,483.00 |
| Sep 30, 2022 | 511,928.00 |
| Jun 30, 2022 | -510,366.00 |
| Mar 31, 2022 | -160,401.00 |
| Dec 31, 2021 | 81,301.00 |
| Sep 30, 2021 | 83,107.00 |
| Jun 30, 2021 | 54,798.00 |